Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Core Insights - Relmada Therapeutics, Inc. is participating in the Leerink Partners Global Healthcare Conference from March 8-11, 2026, with CEO Sergio Traversa and CFO Maged Shenouda attending [1] - The conference will feature a fireside chat on March 10, 2026, at 8:40 AM ET, and management will be available for one-on-one investor meetings [2] Company Overview - Relmada Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for oncology and central nervous system disorders [4] - The company's lead candidates, NDV-01 and sepranolone, are in mid-stage clinical development and aim to address significant unmet medical needs [4]